How many insider declarations has Deep Track Biotechnology Master Fund, Ltd. filed?

Deep Track Biotechnology Master Fund, Ltd. has filed 4 public insider declarations with SEC (Form 4).

What is Deep Track Biotechnology Master Fund, Ltd.'s role?

Deep Track Biotechnology Master Fund, Ltd.'s reported role is not specified by the regulator across the filings.

Which companies does Deep Track Biotechnology Master Fund, Ltd. report trades for?

Deep Track Biotechnology Master Fund, Ltd. reports trades for 3 companies, including Dynavax Technologies CORP.

What is Deep Track Biotechnology Master Fund, Ltd.'s declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 10.4M€.

← Executives ★ Sign in to follow

DT

Deep Track Biotechnology Master Fund, Ltd.

·SEC (Form 4)

Dynavax Technologies CORP LB PHARMACEUTICALS INC Attovia Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€1040万

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Browse the detailed record of transactions filed by Deep Track Biotechnology Master Fund, Ltd.. Insider active across 3 companies, notably Dynavax Technologies CORP. Aggregated, 4 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €10.4m. Activity tracked since 21 August 2025. The latest transaction was filed on 21 August 2025 (Cession). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Deep Track Biotechnology Master Fund, Ltd.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Dynavax Technologies CORP (US)LB PHARMACEUTICALS INC (US)Attovia Therapeutics, Inc. (US)

申报4 总计

●

Deep Track Biotechnology Master Fund, Ltd.

10% Owner高管2026年8月6日Attovia Therapeutics, Inc.

0SEC ↗

1,957,138 股Common StockSEC:0001193125-26-342487:0

●

Deep Track Biotechnology Master Fund, Ltd.

高管2026年2月10日Dynavax Technologies CORP

2SEC ↗

15,726,349 股Common Stock, par value $0.001 per shareSEC:0001193125-26-046675:0

●

Deep Track Biotechnology Master Fund, Ltd.

高管2025年9月12日LB PHARMACEUTICALS INC

2SEC ↗

686,138 股Common StockSEC:0002015536-25-000007:0

▼

Deep Track Biotechnology Master Fund, Ltd.

高管2025年8月21日Dynavax Technologies CORP

US$1208万10SEC ↗

1,094,994 股@ US$11.03100.0% 占其流量Common Stock, par value $0.001 per shareSEC:0000950170-25-111070:0

4 条申报中的 4 条

InsidersTradesSigma

← Executives ★ Sign in to follow

DT

Deep Track Biotechnology Master Fund, Ltd.

·SEC (Form 4)

Dynavax Technologies CORP LB PHARMACEUTICALS INC Attovia Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€1040万

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Browse the detailed record of transactions filed by Deep Track Biotechnology Master Fund, Ltd.. Insider active across 3 companies, notably Dynavax Technologies CORP. Aggregated, 4 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €10.4m. Activity tracked since 21 August 2025. The latest transaction was filed on 21 August 2025 (Cession). Regulator: SEC (Form 4). All data is free.